Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) play complementary roles
in follicle development and ovulation via a complex interaction in the hypothalamus, anterior …

The first commercially available gonadotropin product was a human chorionic gonadotropin
(hCG) extract, followed by animal pituitary gonadotropin extracts. These extracts were …

This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and
embryologists. Its primary objective is to contextualize the Poseidon criteria and their metric …

Despite the considerate progress to which assisted reproduction technology (ART) has been
subject since 1978, some issues remain unresolved. Notably, the clinical management of …

STUDY QUESTION What is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle
in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing …

POSEIDON groups 1 and 2 patients respond poorly (< 4 oocytes retrieved) or sub-optimally
(4–9 oocytes retrieved) to gonadotropin stimulation despite the presence of adequate …

In the POSEIDON classification, patients belonging to groups 3 and 4 share the same
common feature of a poor ovarian reserve which independently of age renders them at high …

The POSEIDON group (P atient-O riented S trategies E ncompassing I ndividualize DO ocyte
N umber) has introduced “the ability to retrieve the number of oocytes needed to achieve at …

STUDY QUESTION Do cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles
confirm the low prognosis in women stratified according to the POSEIDON criteria …

The infertile patients with aging ovaries—also sometimes referred to as impending
premature ovarian insufficiency (POI), impending premature ovarian failure (POF), or poor …